Ефективність бактеріофагів проти Pseudomonas aeruginosa з різними профілями стійкості до антибіотиків

V. A. Poniatovskyi; A. A. Vodianyk; V. P. Shyrobokov; A. V. Kharina

doi:10.14739/2310-1210.2025.5.338971

Authors

V. A. Poniatovskyi Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0002-1503-3935
A. A. Vodianyk Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0002-6307-2701
V. P. Shyrobokov Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0003-0882-148X
A. V. Kharina Taras Shevchenko National University of Kyiv, Ukraine https://orcid.org/0000-0002-0722-6374

DOI:

https://doi.org/10.14739/2310-1210.2025.5.338971

Keywords:

Pseudomonas aeruginosa, bacteriophages, lytic activity spectrum, Bacteriophage-antibiotic interaction

Abstract

With the rising prevalence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) strains of Pseudomonas aeruginosa, the development of alternative therapeutic approaches has become increasingly important. Among these, the use of bacteriophages represents a particularly promising strategy for the treatment of infections caused by multidrug-resistant pathogens.

The aim of this study was to isolate and characterize bacteriophages lytically active against P. aeruginosa, to determine their activity spectrum against clinical isolates, and to assess the potential of combining bacteriophages with antibiotics.

Materials and methods. The lytic activity of bacteriophages was tested against 23 clinical isolates of P. aeruginosa obtained from pediatric bloodstream infections, including strains carrying antibiotic resistance genes bla_NDM-1, bla_IMP, bla_VIM, and bla_TEM. Antimicrobial susceptibility of bacterial isolates was determined using the disk diffusion method according to EUCAST recommendations. Bacteriophages were isolated from wastewater samples collected in Kyiv. Lytic activity was evaluated by the Spot test and a modified agar overlay assay. Morphological characteristics were examined using transmission electron microscopy. Bacteriophage-antibiotic interactions were assessed by a modified disk diffusion method.

Results. Between 2021 and 2024, a total of 62 bacteriophages were isolated from wastewater, belonging to the Myoviridae-like, Siphoviridae-like, and Podoviridae-like morphotypes. Their lytic spectra varied considerably, ranging from narrow specificity (2–4 strains) to the ability to lyse more than 20 clinical bacterial isolates. Overall, 29.0 % of bacteriophages showed activity against multiple strains, and some isolates exhibited a broad host range, with specific lysis observed in up to 91.3 % of tested strains. Combination testing revealed a predominantly synergistic interaction between bacteriophages and β-lactam antibiotics, manifested by an increase in both plaque size and number.

Conclusions. The isolated bacteriophages demonstrated substantial variability in lytic activity and have potential applications in the treatment of infections caused by multidrug-resistant P. aeruginosa strains. The findings support the feasibility of establishing bacteriophage collections and applying combined bacteriophage-antibiotic therapies. Considering the current epidemiological situation in Ukraine, these results are of practical importance for the development of new antimicrobial strategies.

Author Biographies

V. A. Poniatovskyi, Bogomolets National Medical University, Kyiv

MD, PhD, Associate Professor of the Department of Microbiology and Parasitology with the Basics of Immunology

A. A. Vodianyk, Bogomolets National Medical University, Kyiv

PhD student at the Department of Microbiology and Parasitology with the Basics of Immunology, Bogomolets National Medical University, Kyiv

V. P. Shyrobokov, Bogomolets National Medical University, Kyiv

MD, PhD, DSc, Professor, Head of the Department of Microbiology and Parasitology with the Basics of Immunology, Bogomolets National Medical University, Kyiv, Ukraine; Academician of the National Academy of Sciences and the National Academy of Medical Sciences of Ukraine

A. V. Kharina, Taras Shevchenko National University of Kyiv

PhD, Associate Professor of the Department of Virology

References

Gellatly SL, Hancock RE. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013;67(3):159-73. doi: https://doi.org/10.1111/2049-632X.12033

Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7(1):199. doi: https://doi.org/10.1038/s41392-022-01056-1

Healthcare-associated infections acquired in intensive care units – Annual Epidemiological Report for 2020 [Internet]. European Centre for Disease Prevention and Control. 2024 [cited 2025 Sept 2]. Available from: https://www.ecdc.europa.eu/en/publications-data/healthcare-associated-infections-acquired-intensive-care-units-annual

Fernández-Billón M, Llambías-Cabot AE, Jordana-Lluch E, Oliver A, Macià MD. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms. Biofilm. 2023;5:100129. doi: https://doi.org/10.1016/j.bioflm.2023.100129

WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance [Internet]. Who.int. World Health Organization; 2024 [cited 2025 Sept 2]. Available from: https://www.who.int/publications/i/item/9789240093461

Ng QX, Ong NY, Lee D, Yau CE, Lim YL, Kwa A, et al. Trends in Pseudomonas aeruginosa (P. aeruginosa ) Bacteremia during the COVID-19 Pandemic: A Systematic Review. Antibiotics (Basel). 2023;12(2):409. doi: https://doi.org/10.3390/antibiotics12020409

Antimicrobial resistance surveillance in Europe 2023 – 2021 data [Internet]. European Centre for Disease Prevention and Control. 2023 [cited 2025 Sept 2]. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2023-2021-data

Byk PL, Kryvorchuk IH, Leshchyshyn IM, Martyniuk NS, Orlov DY. [Epidemiology and antibiotic resistance of combat wound infection in surgical patients]. Ukrainian Journal of Cardiovascular Surgery. 2024;32(2):129-40. Ukrainian. doi: https://doi.org/10.30702/ujcvs/24.32(02)/bk019-129140

Public Health Centre of the Ministry of Health of Ukraine. [Report on enhanced epidemiological surveillance of antimicrobial resistance in microorganisms causing purulent wound infections in war-injured patients, 2023-2024]. Kyiv: Public Health Centre of the Ministry of Health of Ukraine; 2025. Ukrainian.

Hahn A, Sami I, Chaney H, Koumbourlis AC, Del Valle Mojica C, Cochrane C, et al. Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis. J Investig Med High Impact Case Rep. 2023;11:23247096231188243. doi: https://doi.org/10.1177/23247096231188243

Köhler T, Luscher A, Falconnet L, Resch G, McBride R, Mai QA, et al. Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa. Nat Commun. 2023;14(1):3629. doi: https://doi.org/10.1038/s41467-023-39370-z. Erratum in: Nat Commun. 2023;14(1):4443. doi: https://doi.org/10.1038/s41467-023-40202-3

Blasco L, López-Hernández I, Rodríguez-Fernández M, Pérez-Florido J, Casimiro-Soriguer CS, Djebara S, et al. Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection. Front Med (Lausanne). 2023;10:1199657. doi: https://doi.org/10.3389/fmed.2023.1199657

Ferry T, Kolenda C, Laurent F, Leboucher G, Merabischvilli M, Djebara S, et al. Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection. Nat Commun. 2022;13(1):4239. doi: https://doi.org/10.1038/s41467-022-31837-9

Markoishvili K, Tsitlanadze G, Katsarava R, Morris JG Jr, Sulakvelidze A. A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int J Dermatol. 2002;41(7):453-8. doi: https://doi.org/10.1046/j.1365-4362.2002.01451.x

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0 [Internet]. Eucast.org. [cited 2025 Sept 2]. Available from: https://www.eucast.org

European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing. Version 13.0 [Internet]. Eucast.org. [cited 2025 Sept 2]. Available from: https://www.eucast.org

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: https://doi.org/10.1111/j.1469-0691.2011.03570.x

Paranos P, Pournaras S, Meletiadis J. A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens. J Clin Microbiol. 2024;62(8):e0074324. doi: https://doi.org/10.1128/jcm.00743-24

Li P, Yin R, Cheng J, Lin J. Bacterial Biofilm Formation on Biomaterials and Approaches to Its Treatment and Prevention. Int J Mol Sci. 2023;24(14):11680. doi: https://doi.org/10.3390/ijms241411680

Bondarenko AV, Chumachenko IV, Dotsenko NV, Bondarenko OV, Katsapov DV, Neskoromna NV, et al. MBL encoding genes in gram-negative ESKAPE pathogens from the bloodstream of ICU COVID-19 patients. Odessa Medical Journal. 2024;(5):40-4. doi: https://doi.org/10.32782/2226-2008-2024-5-6

Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, et al. Detection of metallo-β-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis. 2010;68(3):322-5. doi: https://doi.org/10.1016/j.diagmicrobio.2010.06.018

Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae. Version 2.0. [Internet]. European Centre for Disease Prevention and Control. 2019 [cited 2025 Sept 2]. Available from: https://www.ecdc.europa.eu/en/publications-data/laboratory-manual-carbapenem-and-colistin-resistance-detection-and

Dai F, Yang G, Lou J, Zhao X, Chen M, Sun G, et al. Isolation and Characterization of Pseudomonas aeruginosa Phages with a Broad Host Spectrum from Hospital Sewage Systems and Their Therapeutic Effect in a Mouse Model. Am J Trop Med Hyg. 2023;108(6):1220-6. doi: https://doi.org/10.4269/ajtmh.22-0303

Farlow J, Freyberger HR, He Y, Ward AM, Rutvisuttinunt W, Li T, et al. Complete Genome Sequences of 10 Phages Lytic against Multidrug-Resistant Pseudomonas aeruginosa. Microbiol Resour Announc. 2020;9(29):e00503-20. doi: https://doi.org/10.1128/MRA.00503-20

Holger DJ, Lev KL, Kebriaei R, Morrisette T, Shah R, Alexander J, et al. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. J Appl Microbiol. 2022;133(3):1636-49. doi: https://doi.org/10.1111/jam.15647

Ferran AA, Lacroix MZ, Gourbeyre O, Huesca A, Gaborieau B, Debarbieux L, et al. The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination. Microbiol Spectr. 2022;10(5):e0287422. doi: https://doi.org/10.1128/spectrum.02874-22

Kim HY, Chang RY, Morales S, Chan HK. Bacteriophage-Delivering Hydrogels: Current Progress in Combating Antibiotic Resistant Bacterial Infection. Antibiotics (Basel). 2021;10(2):130. doi: https://doi.org/10.3390/antibiotics10020130

Shafigh Kheljan F, Sheikhzadeh Hesari F, Aminifazl MS, Skurnik M, Goladze S, Zarrini G. Design of Phage-Cocktail-Containing Hydrogel for the Treatment of Pseudomonas aeruginosa-Infected Wounds. Viruses. 2023;15(3):803. doi: https://doi.org/10.3390/v15030803